DESY has successfully concluded tests of the first section of the particle accelerator for the European X-ray free-electron laser, European XFEL. The so-called electron injector, which is 30 metres long, performed distinctly better than expected. The injector already completed a whole week under operating conditions. “Having gathered much valuable experience, we are now all set to start up the entire accelerator complex,” reports Winfried Decking, the machine coordinator at DESY. “This is a huge success for the entire accelerator team, together with our international partners.”

Built in an international collaboration in the Hamburg metropolitan area, the world’s best X-ray laser, the European XFEL, is about to be completed. It will produce extremely bright and ultra-short X-ray pulses, permitting a multitude of experiments to be carried out in the nanocosm – from determining the precise atomic structure of pathogens, to making ultra-slow-motion films of chemical reactions. The bright X-ray light is produced by small bunches of high-energy electrons which are brought to speed by a particle accelerator and then sent down an undulating magnetic path. At each magnetic bend in the path, the electron bunches emit X-rays which add up to a laser-like pulse in a self-amplifying manner.

DESY is the main shareholder of the company European XFEL GmbH and responsible, among other things, for building and operating the 2.1-kilometre particle accelerator. The injector is located at the very beginning of the accelerator. Its task is to supply tailor-made bunches of electrons to the main accelerator. The quality of these electron bunches is crucial to the quality of the X-ray laser pulses at the experimental stations, about 3.5 kilometres away. One important quality criterion is how narrowly the electron bunches can be focussed. “This so-called emittance is some 40 percent better than specified,” reports Decking.

Ten times every second, the injector produces a train of up to 2700 short bunches of electrons. To test the quality of the beam, a special diagnostic system picks out individual bunches. “We need only about four bunches per train to analyse the beam,” explains Decking. These bunches are tilted by a cavity before striking the diagnostic screen. The elongated image they leave behind as a result can be used to study the longitudinal structure of each bunch in detail. The analysis reveals the outstanding quality of the bunches.

In the past seven months, the injector, which produced its first electron beam in December, has given the accelerator team an opportunity to get to know all major subsystems of the entire accelerator facility: “The injector includes all the subsystems that are used in the main accelerator too,” says Decking. “This meant we were able to test and familiarise ourselves with them.” All in all, he says, no major obstacles were encountered throughout the several months of its test operation. The injector went offline on Monday, so that it can be connected to the main accelerator, for which commissioning is expected to start in October 2016. The whole facility is expected to be available for experiments as from the summer of 2017.

Apart from DESY and European XFEL GmbH, the Centre national de la recherche scientifique CNRS in Orsay (France), the Commissariat à l’énergie atomique et aux énergies alternatives CEA in Saclay (France), the Istituto Nazionale di Fisica Nucleare INFN in Milan (Italy), the Narodowe Centrum Badan Jadrowych in Swierk (Poland), the Wroclaw University of Technology WUT in Wroclaw (Poland), the Instytut Fizyki Jadrowej IFJ-PAN in Krakow (Poland), the Institute for High-Energy Physics in Protvino (Russia), the Efremov Institute NIIEFA in St. Petersburg (Russia), the Budker Institute for Nuclear Physics BINP in Novosibirsk (Russia), the Institute for Nuclear Research INR in Moscow (Russia), the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas CIEMAT in Madrid (Spain), the Universidad Politécnica de Madrid UPM in Madrid (Spain), the University of Stockholm (Sweden), the University of Uppsala (Sweden) and the Paul Scherrer Institute in Villigen (Switzerland) are also involved in the injector.